
APR-246
CAS No. 5291-32-7
APR-246 ( PRIMA-1MET )
产品货号. M14875 CAS No. 5291-32-7
APR-246 (PRIMA-1MET) 是 PRIMA-1 的甲基化衍生物,可恢复突变型 p53 活性。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥543 | 有现货 |
![]() ![]() |
10MG | ¥867 | 有现货 |
![]() ![]() |
25MG | ¥1758 | 有现货 |
![]() ![]() |
50MG | ¥3135 | 有现货 |
![]() ![]() |
100MG | ¥5565 | 有现货 |
![]() ![]() |
500MG | ¥11259 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称APR-246
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述APR-246 (PRIMA-1MET) 是 PRIMA-1 的甲基化衍生物,可恢复突变型 p53 活性。
-
产品描述APR-246 (PRIMA-1MET) is a methylated derivative of PRIMA-1 that restores mutant p53 activity, acts synergistically with chemotherapeutic agents to inhibit tumor cell proliferation; also restores the pro-apoptotic function to mutant TAp63γ and TAp73β in tumor cells but has less effect on TAp73α;induces mutant p53-dependent mitochondria-mediated apoptosis through activation of caspase-2 with subsequent cytochrome c release and further activation of downstream caspase-9 and caspase-3; inhibits tumor xenograft growth in vivo.Ovarian Cancer Phase 2 Clinical.
-
体外实验——
-
体内实验——
-
同义词PRIMA-1MET
-
通路Apoptosis
-
靶点MDM2-p53
-
受体p53activator|TrxR1inhibitor
-
研究领域Cancer
-
适应症Ovarian Cancer
化学信息
-
CAS Number5291-32-7
-
分子量199.25
-
分子式C10H17NO3
-
纯度>98% (HPLC)
-
溶解度DMSO: 20mg/mL ( < 1 mg/ml refers to the product slightly soluble or insoluble )
-
SMILESO=C1C(COC)(CO)N2CCC1CC2
-
化学全称2-(Hydroxymethyl)-2-(methoxymethyl)-1-azabicyclo[2.2.2]octan-3-one
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Shen J, et al. Oncogene. 2008 Nov 20;27(51):6571-80.
2. Bykov VJ, et al. Oncogene. 2005 May 12;24(21):3484-91.
3. R?kaeus N, et al. Oncogene. 2010 Dec 9;29(49):6442-51.